Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ID: DRG0OJEQD)
| ADC Name |
SCR-A002
|
|||||
|---|---|---|---|---|---|---|
| Synonyms |
SCR-A002
Click to Show/Hide
|
|||||
| Organization |
Simcere Zaiming Pharmaceutical Co., Ltd., Shanghai, China
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
8
|
|||||
| Antibody Name |
Bemarituzumab
|
Antibody Info | ||||
| Antigen Name |
Fibroblast growth factor receptor 2 (FGFR2)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Linker Name |
Undisclosed
|
|||||